article thumbnail

The drug industry continues to dare regulation

World of DTC Marketing

The study adds further evidence to the idea that drug copay cards are a great short-term deal for patients — and especially the pharma companies that promote them — but a wrong long-term value for healthcare costs. The post The drug industry continues to dare regulation appeared first on World of DTC Marketing.com.

article thumbnail

Novartis, Genentech and others named in Italian anti-competition probe

Pharmaceutical Technology

Italy’s anti-trust regulator AGCM has launched an anti-competition probe into several pharma companies over alleged anti-competitive conduct.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How are pharma companies addressing sustainability and climate change?

Outsourcing Pharma

The pharmaceutical industry is making significant strides toward sustainability, with companies across the sector implementing various Environmental, Social, and Governance (ESG) initiatives.

article thumbnail

UK Regulator Fines Pharma Companies for 10,000% Drug Price Increase

BioSpace

?The CMA said some pharmaceutical firms charge the NHS with excessively high prices for hydrocortisone tablets and paid off potential competitors to stay out of the market.

article thumbnail

MHRA publishes guidance on medicine regulation after Brexit

pharmaphorum

The UK’s medicines regulator has published long-awaited guidance on regulation of medicines and medical devices as the UK approaches the end of its Brexit transition period at the end of the year. Companies face significant changes in how the complex environment for medicines regulations will operate in 2021. “If

article thumbnail

Four things you need to know about FDA regulations and digital health

pharmaphorum

If you work in pharma, the chances are you’re no stranger to the United States Food and Drug Administration, or FDA, which regulates pharmaceuticals. While the FDA is responsible for regulating both drugs and devices, they’re handled through completely different processes in different parts of the agency.

article thumbnail

What can pharma companies do to get promising antimicrobials to the frontlines of drug resistance?

Outsourcing Pharma

A new report from Access to Medicine Foundation gives the advice to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance.